Literature DB >> 29704670

Anti-inflammatory effects of isorhamnetin on LPS-stimulated human gingival fibroblasts by activating Nrf2 signaling pathway.

Feng Qi1, Ji-Hao Sun1, Jia-Qun Yan2, Chun-Mei Li3, Xue-Chao Lv4.   

Abstract

Periodontitis is a highly prevalent infective and inflammatory disease with an adverse impact on systemic health. Isorhamnetin, a flavonoid mainly isolated from Hippophae fhamnoides L. fruit, has been reported to have anti-inflammatory effect. This study aimed to investigate the anti-inflammatory effects and mechanism of isorhamnetin on lipopolysaccharide (LPS)-induced inflammatory response in human gingival fibroblasts (HGFs). The production of inflammatory mediators and the expression of proteins were measured by ELISA and western blot analysis. The results demonstrated that isorhamnetin attenuated LPS-induced release of PGE2, NO, IL-6, and IL-8 in HGFs. Isorhamnetin also inhibited LPS-induced NF-κB activation. The expression of Nrf2 and HO-1 were up-regulated by treatment of isorhamnetin. Furthermore, knockdown of Nrf2 by siRNA reversed the anti-inflammatory effects of isorhamnetin. In conclusion, these results suggested that isorhamnetin inhibited LPS-induced inflammation in HGFs by activating Nrf2 signaling pathway.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Human gingival fibroblasts; IL-8; Isorhamnetin; LPS; Nrf2

Mesh:

Substances:

Year:  2018        PMID: 29704670     DOI: 10.1016/j.micpath.2018.04.049

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  14 in total

1.  Eldecalcitol Inhibits LPS-Induced NLRP3 Inflammasome-Dependent Pyroptosis in Human Gingival Fibroblasts by Activating the Nrf2/HO-1 Signaling Pathway.

Authors:  Cancan Huang; Chaotao Zhang; Panpan Yang; Rui Chao; Ziqi Yue; Congshan Li; Jie Guo; Minqi Li
Journal:  Drug Des Devel Ther       Date:  2020-11-13       Impact factor: 4.162

2.  Isorhamnetin inhibits amplification of influenza A H1N1 virus inflammation mediated by interferon via the RIG-I/JNK pathway.

Authors:  Jing Li; Yifan Xu; Zhiwei Lin; Lili Guan; Shuqi Chen; Luqian Zhou
Journal:  Ann Transl Med       Date:  2021-08

3.  Development of a Mucoadhesive and an in Situ Gelling Formulation Based on κ-Carrageenan for Application on Oral Mucosa and Esophagus Walls. II. Loading of a Bioactive Hydroalcoholic Extract.

Authors:  Barbara Vigani; Silvia Rossi; Matteo Gentile; Giuseppina Sandri; Maria Cristina Bonferoni; Valeria Cavalloro; Emanuela Martino; Simona Collina; Franca Ferrari
Journal:  Mar Drugs       Date:  2019-03-05       Impact factor: 5.118

4.  Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells.

Authors:  Cheol Park; Hee-Jae Cha; Eun Ok Choi; Hyesook Lee; Hyun Hwang-Bo; Seon Yeong Ji; Min Yeong Kim; So Young Kim; Su Hyun Hong; JaeHun Cheong; Gi-Young Kim; Seok Joong Yun; Hye Jin Hwang; Wun-Jae Kim; Yung Hyun Choi
Journal:  Cancers (Basel)       Date:  2019-10-04       Impact factor: 6.639

5.  Isorhamnetin Has Potential for the Treatment of Escherichia coli-Induced Sepsis.

Authors:  Anil Kumar Chauhan; Jieun Kim; Yeongjoon Lee; Pavithra K Balasubramanian; Yangmee Kim
Journal:  Molecules       Date:  2019-11-04       Impact factor: 4.411

6.  Isorhamnetin Ameliorates Aspergillus fumigatus Keratitis by Reducing Fungal Load, Inhibiting Pattern-Recognition Receptors and Inflammatory Cytokines.

Authors:  Xue Tian; Xudong Peng; Jing Lin; Yingxue Zhang; Lu Zhan; Jiao Yin; Ranran Zhang; Guiqiu Zhao
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-03-01       Impact factor: 4.799

7.  NRF2 Exerts Anti-Inflammatory Effects in LPS-Induced gEECs by Inhibiting the Activation of the NF-κB.

Authors:  Hongchu Bao; Qinglan Qu; Wei Zhang; Xinrong Wang; Jianye Fang; Jinwen Xue; Zhenteng Liu; Shunzhi He
Journal:  Mediators Inflamm       Date:  2021-11-02       Impact factor: 4.711

8.  Isorhamnetin alleviates lipopolysaccharide-induced inflammatory responses in BV2 microglia by inactivating NF-κB, blocking the TLR4 pathway and reducing ROS generation.

Authors:  Shin Young Kim; Cheng-Yun Jin; Cheol Hong Kim; Young Hyun Yoo; Sung Hyun Choi; Gi-Young Kim; Hyun Min Yoon; Hwan Tae Park; Yung Hyun Choi
Journal:  Int J Mol Med       Date:  2018-11-20       Impact factor: 4.101

Review 9.  Nrf2 in the Field of Dentistry with Special Attention to NLRP3.

Authors:  Lisa Schieffer; Claudia Manzl; Christoph Schatz; Johannes Haybaeck; Adriano Crismani
Journal:  Antioxidants (Basel)       Date:  2022-01-12

10.  Anhydroexfoliamycin, a Streptomyces Secondary Metabolite, Mitigates Microglia-Driven Inflammation.

Authors:  Sandra Gegunde; Amparo Alfonso; Rebeca Alvariño; Nadia Pérez-Fuentes; Luis M Botana
Journal:  ACS Chem Neurosci       Date:  2021-06-10       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.